Skip to main content

Chronic Pain News (Page 2)

Over-the-Counter Meds, Exercise Most Prevalent Treatment for Chronic Pain

MONDAY, Nov. 20, 2023 – For adults with chronic pain, the most prevalent pain management therapies were over-the-counter pain relievers and exercise in 2020, according to a research letter published...

Few Adults Talk to Providers About BP Risks of OTC Pain Relievers

TUESDAY, Nov. 7, 2023 – Only about 30 percent of U.S. adults have spoken with their health care professional about the adverse effects some over-the-counter pain relievers can have on blood...

1 in 5 U.S. Adults Now Has Arthritis

TUESDAY, Oct. 17, 2023 – Arthritis is becoming a disease of the masses, striking 21% of U.S. adults, or over 53 million people, a new report shows. “It's important first to point out that arthritis i...

Four SNPs Linked to Chronic Complex Regional Pain Syndrome Type 1

FRIDAY, Oct. 13, 2023 – Four single nucleotide polymorphisms (SNPs) in four genes are associated with chronic complex regional pain syndrome type 1 (CRPS-1), according to a study published online...

Cannabis Use Relatively Common Among Midlife Women

WEDNESDAY, Sept. 27, 2023 – Current and lifetime medical and recreational cannabis use is relatively common among midlife women, according to a study presented at the annual meeting of the North...

Psychotherapy May Help Ease Fibromyalgia Pain

MONDAY, Sept. 25, 2023 – "Talk therapy" may help people with fibromyalgia manage their chronic pain – and alter the brain's pain-processing circuitry along the way, a new study shows. Researchers...

Cognitive-Behavioral Therapy Helps Relieve Fibromyalgia Pain

FRIDAY, Sept. 22, 2023 – Cognitive-behavioral therapy (CBT) is superior to a matched education treatment in reducing the interfering effects of pain and other aspects of fibromyalgia, according to a...

High-Dose VX-548 Reduces Acute Pain Over 48 Hours

FRIDAY, Aug. 4, 2023 – High-dose VX-548, an oral, highly selective inhibitor of the Nav1.8 voltage-gated sodium channel, reduces acute pain over 48 hours after abdominoplasty and bunionectomy,...

Study Links Greater Number of Chronic Pain Sites to Risk for Dementia

WEDNESDAY, July 12, 2023 – A greater number of chronic pain sites is associated with an increased risk for incident all-cause dementia and Alzheimer disease, according to a study recently published...

Access to Medical Marijuana Won't Lower Use of Opioid Painkillers: Study

WEDNESDAY, July 5, 2023 – Medical marijuana is touted as a pain reliever, but in U.S. states where it's legal, prescriptions for opioid or non-opioid painkillers haven't decreased, a new study...

FDA Approves Arymo ER (morphine sulfate) Abuse-Deterrent Formulation for the Treatment of Chronic Pain

WAYNE, Penn., Jan. 9, 2017 /PRNewswire/ – Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing...

FDA Approves Belbuca (buprenorphine) Buccal Film for Chronic Pain Management

DUBLIN and RALEIGH, N.C., October 26, 2015 – Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), and BioDelivery Sciences International, Inc. (NASDAQ: BDSI),...

FDA Approves Targiniq ER Extended-Release Oxycodone with Abuse-Deterrent Properties

July 23, 2014 – Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Pain

Related drug support groups

tramadol, gabapentin, Cymbalta, ibuprofen, oxycodone, hydrocodone, naproxen, acetaminophen, amitriptyline, view more... Percocet, pregabalin, duloxetine, diclofenac, methadone, OxyContin, codeine, fentanyl, morphine, nortriptyline, buprenorphine, Butrans, Dilaudid, Roxicodone, Percocet 10/325, hydromorphone